0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Serplulimab Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33S14147
Home | Market Reports | Science| Engineering & Technology
Global Serplulimab Injection Market Research Report 2023
BUY CHAPTERS

Global Serplulimab Injection Market Research Report 2025

Code: QYRE-Auto-33S14147
Report
May 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Serplulimab Injection Market Size

The global market for Serplulimab Injection was valued at US$ 4.2 million in the year 2024 and is projected to reach a revised size of US$ 57.5 million by 2031, growing at a CAGR of 45.8% during the forecast period.

Serplulimab Injection Market

Serplulimab Injection Market

Serplulimab (also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech.
North American market for Serplulimab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Serplulimab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Serplulimab Injection include Shanghai Henlius Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Serplulimab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serplulimab Injection.
The Serplulimab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Serplulimab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Serplulimab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Serplulimab Injection Market Report

Report Metric Details
Report Name Serplulimab Injection Market
Accounted market size in year US$ 4.2 million
Forecasted market size in 2031 US$ 57.5 million
CAGR 45.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 100mg/10ml
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shanghai Henlius Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Serplulimab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Serplulimab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Serplulimab Injection Market growing?

Ans: The Serplulimab Injection Market witnessing a CAGR of 45.8% during the forecast period 2025-2031.

What is the Serplulimab Injection Market size in 2031?

Ans: The Serplulimab Injection Market size in 2031 will be US$ 57.5 million.

Who are the main players in the Serplulimab Injection Market report?

Ans: The main players in the Serplulimab Injection Market are Shanghai Henlius Biotech

What are the Application segmentation covered in the Serplulimab Injection Market report?

Ans: The Applications covered in the Serplulimab Injection Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Serplulimab Injection Market report?

Ans: The Types covered in the Serplulimab Injection Market report are 100mg/10ml, Others

Recommended Reports

Oncology & Immunotherapy

Injection & Drug Delivery

Vaccines & Adjuvants

1 Serplulimab Injection Market Overview
1.1 Product Definition
1.2 Serplulimab Injection by Type
1.2.1 Global Serplulimab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 100mg/10ml
1.2.3 Others
1.3 Serplulimab Injection by Application
1.3.1 Global Serplulimab Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Serplulimab Injection Market Size Estimates and Forecasts
1.4.1 Global Serplulimab Injection Revenue 2020-2031
1.4.2 Global Serplulimab Injection Sales 2020-2031
1.4.3 Global Serplulimab Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Serplulimab Injection Market Competition by Manufacturers
2.1 Global Serplulimab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Serplulimab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Serplulimab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Serplulimab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Serplulimab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Serplulimab Injection, Product Type & Application
2.7 Global Key Manufacturers of Serplulimab Injection, Date of Enter into This Industry
2.8 Global Serplulimab Injection Market Competitive Situation and Trends
2.8.1 Global Serplulimab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Serplulimab Injection Players Market Share by Revenue
2.8.3 Global Serplulimab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Serplulimab Injection Market Scenario by Region
3.1 Global Serplulimab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Serplulimab Injection Sales by Region: 2020-2031
3.2.1 Global Serplulimab Injection Sales by Region: 2020-2025
3.2.2 Global Serplulimab Injection Sales by Region: 2026-2031
3.3 Global Serplulimab Injection Revenue by Region: 2020-2031
3.3.1 Global Serplulimab Injection Revenue by Region: 2020-2025
3.3.2 Global Serplulimab Injection Revenue by Region: 2026-2031
3.4 North America Serplulimab Injection Market Facts & Figures by Country
3.4.1 North America Serplulimab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Serplulimab Injection Sales by Country (2020-2031)
3.4.3 North America Serplulimab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Serplulimab Injection Market Facts & Figures by Country
3.5.1 Europe Serplulimab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Serplulimab Injection Sales by Country (2020-2031)
3.5.3 Europe Serplulimab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serplulimab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Serplulimab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Serplulimab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Serplulimab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Serplulimab Injection Market Facts & Figures by Country
3.7.1 Latin America Serplulimab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Serplulimab Injection Sales by Country (2020-2031)
3.7.3 Latin America Serplulimab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Serplulimab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Serplulimab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Serplulimab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Serplulimab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Serplulimab Injection Sales by Type (2020-2031)
4.1.1 Global Serplulimab Injection Sales by Type (2020-2025)
4.1.2 Global Serplulimab Injection Sales by Type (2026-2031)
4.1.3 Global Serplulimab Injection Sales Market Share by Type (2020-2031)
4.2 Global Serplulimab Injection Revenue by Type (2020-2031)
4.2.1 Global Serplulimab Injection Revenue by Type (2020-2025)
4.2.2 Global Serplulimab Injection Revenue by Type (2026-2031)
4.2.3 Global Serplulimab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Serplulimab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Serplulimab Injection Sales by Application (2020-2031)
5.1.1 Global Serplulimab Injection Sales by Application (2020-2025)
5.1.2 Global Serplulimab Injection Sales by Application (2026-2031)
5.1.3 Global Serplulimab Injection Sales Market Share by Application (2020-2031)
5.2 Global Serplulimab Injection Revenue by Application (2020-2031)
5.2.1 Global Serplulimab Injection Revenue by Application (2020-2025)
5.2.2 Global Serplulimab Injection Revenue by Application (2026-2031)
5.2.3 Global Serplulimab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Serplulimab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shanghai Henlius Biotech
6.1.1 Shanghai Henlius Biotech Company Information
6.1.2 Shanghai Henlius Biotech Description and Business Overview
6.1.3 Shanghai Henlius Biotech Serplulimab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shanghai Henlius Biotech Serplulimab Injection Product Portfolio
6.1.5 Shanghai Henlius Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serplulimab Injection Industry Chain Analysis
7.2 Serplulimab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serplulimab Injection Production Mode & Process Analysis
7.4 Serplulimab Injection Sales and Marketing
7.4.1 Serplulimab Injection Sales Channels
7.4.2 Serplulimab Injection Distributors
7.5 Serplulimab Injection Customer Analysis
8 Serplulimab Injection Market Dynamics
8.1 Serplulimab Injection Industry Trends
8.2 Serplulimab Injection Market Drivers
8.3 Serplulimab Injection Market Challenges
8.4 Serplulimab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Serplulimab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Serplulimab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Serplulimab Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Serplulimab Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Serplulimab Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Serplulimab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Serplulimab Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Serplulimab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Serplulimab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Serplulimab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Serplulimab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Serplulimab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Serplulimab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serplulimab Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Serplulimab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Serplulimab Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Serplulimab Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Serplulimab Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Serplulimab Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Serplulimab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Serplulimab Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Serplulimab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Serplulimab Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Serplulimab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Serplulimab Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Serplulimab Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Serplulimab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Serplulimab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Serplulimab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Serplulimab Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Serplulimab Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Serplulimab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Serplulimab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Serplulimab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Serplulimab Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Serplulimab Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Serplulimab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Serplulimab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Serplulimab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Serplulimab Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Serplulimab Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Serplulimab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Serplulimab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Serplulimab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Serplulimab Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Serplulimab Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Serplulimab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Serplulimab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Serplulimab Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Serplulimab Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Serplulimab Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Serplulimab Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Serplulimab Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Serplulimab Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Serplulimab Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Serplulimab Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Serplulimab Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Serplulimab Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Serplulimab Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Serplulimab Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Serplulimab Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Serplulimab Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Serplulimab Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Serplulimab Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Serplulimab Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Serplulimab Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Serplulimab Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Serplulimab Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Shanghai Henlius Biotech Company Information
 Table 71. Shanghai Henlius Biotech Description and Business Overview
 Table 72. Shanghai Henlius Biotech Serplulimab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Shanghai Henlius Biotech Serplulimab Injection Product
 Table 74. Shanghai Henlius Biotech Recent Developments/Updates
 Table 75. Key Raw Materials Lists
 Table 76. Raw Materials Key Suppliers Lists
 Table 77. Serplulimab Injection Distributors List
 Table 78. Serplulimab Injection Customers List
 Table 79. Serplulimab Injection Market Trends
 Table 80. Serplulimab Injection Market Drivers
 Table 81. Serplulimab Injection Market Challenges
 Table 82. Serplulimab Injection Market Restraints
 Table 83. Research Programs/Design for This Report
 Table 84. Key Data Information from Secondary Sources
 Table 85. Key Data Information from Primary Sources
 Table 86. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Serplulimab Injection
 Figure 2. Global Serplulimab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Serplulimab Injection Market Share by Type: 2024 & 2031
 Figure 4. 100mg/10ml Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Serplulimab Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Serplulimab Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Serplulimab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Serplulimab Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Serplulimab Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Serplulimab Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Serplulimab Injection Report Years Considered
 Figure 16. Serplulimab Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Serplulimab Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Serplulimab Injection Players: Market Share by Revenue in Serplulimab Injection in 2024
 Figure 19. Serplulimab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Serplulimab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Serplulimab Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Serplulimab Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Serplulimab Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Serplulimab Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Serplulimab Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Serplulimab Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Serplulimab Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Serplulimab Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Serplulimab Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Serplulimab Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Serplulimab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Serplulimab Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Serplulimab Injection by Type (2020-2031)
 Figure 53. Global Serplulimab Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Serplulimab Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Serplulimab Injection by Application (2020-2031)
 Figure 56. Global Serplulimab Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Serplulimab Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Civil Engineering Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20Y6111
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Humanoid Robot Bearings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12J17457
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global CAD in Industrial Machinery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32J5952
Fri Sep 12 00:00:00 UTC 2025

Add to Cart